Navigation Links
Intellect Neurosciences, Inc. and Medical Research Council Technology (U.K.) Reach Important Milestone in Generating an Alzheimer's Therapeutic Antibody
Date:6/24/2008

NEW YORK, June 24 /PRNewswire-FirstCall/ -- Intellect Neurosciences, Inc. (OTC Bulletin Board: ILNS) and MRC Technology (MRCT) announced today they have achieved an important milestone through their collaborative efforts to humanize Intellect's lead antibody IN-N01 necessary for creating a therapeutic antibody for the treatment of Alzheimer's disease. The antibody is intended to be used to promote clearance from the brain of beta amyloid, the toxin that leads to Alzheimer's disease. IN-N01 is Intellect's first drug candidate based on the technology invented by Dr. Daniel Chain, the Company's Chairman and CEO.

Dr. Chain commented: "IN-N01 is designed to specifically block the neurotoxicity of beta amyloid, which accumulates in the brains of Alzheimer's patients, while minimizing the potential for adverse effects." Dr. Chain added: "IN-N01 is similar to Bapineuzumab being developed independently by Wyeth and Elan Pharma International Ltd. (Elan) in that it binds the same portion of the toxin, but we are engineering IN-N01 with the aim of reducing its potential to cause inflammation in the brain and so increase the dose at which it can be administered safely. The effectiveness of our strategy will ultimately be tested in patient clinical trials. The recent announcement by Wyeth and Elan of positive Top Line Phase 2 data in a subset of patients is encouraging for this prototype drug and also opens a large window of opportunity for Intellect to develop next generation molecules. We hope that IN-N01 will be the Best-in-Class of the ANTISENILIN(R) antibody family and useful to treat a potentially broader population of Alzheimer's patients."

Intellect recently announced that it has granted a royalty-bearing license to Wyeth and Elan Pharma International Ltd. (Elan) regarding patents and patent applications related to antibodies and methods of treatment for Alzheimer's disease including a co-exclusive license to Bapineuzumab under the ANTISENILIN(R) pate
'/>"/>

SOURCE Intellect Neurosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
2. Intellect Neurosciences, Inc. and CHDI, Inc. Enter Into Compound Testing Agreement to Evaluate OXIGON(TM) as a Potential Treatment for Huntington Disease
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
5. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
6. Globus Medical Raises $110 Million in Series E Financing Round
7. Quark Pharmaceuticals Appoints New Chief Medical Officer
8. Boston University Biomedical Engineers Find Chink in Bacterias Armor
9. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
10. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
11. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... , May 5, 2015  American Laboratory Trading, ... in North America, has named industry veteran Anggie Becorest ... Development. Becorest will be based out of the company,s ... role will include expanding the company,s west coast operations, ... opportunities. "ALT has been the leader in ...
(Date:5/5/2015)... Calif., May 5, 2015 Isis Pharmaceuticals, Inc. ... income of $4.0 million for the three months ended ... operating loss of $22.6 million for the same period ... to higher revenue from milestone payments earned from its ... a GAAP basis, Isis reported a loss from operations ...
(Date:5/5/2015)... Scientific Corporation (NASDAQ: KEQU ) announced today the election ... of Directors, effective April 29, 2015. Mr. Gehl is a ... The election of Mr. Gehl is in conjunction with ... his intention to resign from the Board, effective May 29, ... Mr. Gehl was also elected chair of the Audit Committee, ...
Breaking Medicine Technology:ALT Names Anggie Becorest Senior Vice President of Business Development 2Isis Reports Financial Results and Highlights for First Quarter 2015 2Isis Reports Financial Results and Highlights for First Quarter 2015 3Isis Reports Financial Results and Highlights for First Quarter 2015 4Isis Reports Financial Results and Highlights for First Quarter 2015 5Isis Reports Financial Results and Highlights for First Quarter 2015 6Isis Reports Financial Results and Highlights for First Quarter 2015 7Isis Reports Financial Results and Highlights for First Quarter 2015 8Isis Reports Financial Results and Highlights for First Quarter 2015 9Isis Reports Financial Results and Highlights for First Quarter 2015 10Isis Reports Financial Results and Highlights for First Quarter 2015 11Isis Reports Financial Results and Highlights for First Quarter 2015 12Isis Reports Financial Results and Highlights for First Quarter 2015 13Keith M. Gehl Elected to Kewaunee Scientific Board of Directors 2Keith M. Gehl Elected to Kewaunee Scientific Board of Directors 3
... Findings Show Survival Improvement with Lower Doses ... and other,Drugs in Newly Diagnosed Myeloma -, ... -- The,International Myeloma Foundation (IMF) - supporting ... myeloma patients,families, researchers and physicians - today ...
... April 5, 2007-- Stent thrombosis,restenosis and lifelong prescriptions. ... used as part of their heart,operations may be ... than medical experts have ever publicly acknowledged. Recent,articles ... drug-eluting stents continue to take blood thinners, they,could ...
Cached Medicine Technology:The International Myeloma Foundation Says New Clinical Trial,Results Could Improve Survival While Reducing Side Effects For Many,Patients 2The International Myeloma Foundation Says New Clinical Trial,Results Could Improve Survival While Reducing Side Effects For Many,Patients 3New Cardioprotective Drug Could Provide Boost For Post-Bypass,Surgery Heart Health 2
(Date:5/5/2015)... (PRWEB) May 05, 2015 Major League ... with the belief that ultimate Frisbee™ is home to ... next sport that engages the world. Nike Ultimate Camps’ ... by creating opportunities for young athletes to learn about ... with MLU the perfect fit. , The Nike Ultimate ...
(Date:5/5/2015)... 05, 2015 Igantia , an ... leads an international initiative to examine key biological milestones ... human lifespan. Scientists at Igantia believe that better ... the initiation of her menstrual cycle to her transition ... aging and, ultimately, extend the lifespan. , By ...
(Date:5/5/2015)... May 05, 2015 After record-breaking sales ... in 2014, Walgreens introduces the Cookies & Cream flavor ... innovation, Extend Nutrition has continually raised the bar for ... taste, combined with an unprecedented nutritional profile, backed by ... success, Extend Nutrition will launch additional new products and ...
(Date:5/5/2015)... Kan. (PRWEB) May 05, 2015 B. ... exclusively to healthcare providers, has been retained to recruit ... in Helena, Mont. The top executive search firm in ... more than 900 healthcare executives into organizations. , Shodair ... treatment facility in Montana to offer both acute and ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 Atlantic ... Week, AIS’s Directory of Health Plans, and other ... announce its new monthly newsletter, AIS’s Value-Based Care ... systems, physician groups, pharma companies and their advisers, ... (ACOs), medical homes, bundled payments, coordinated care, global ...
Breaking Medicine News(10 mins):Health News:US Sports Camps, Nike Ultimate Camps, and Major League Ultimate Host Youth Ultimate Summer Camps in Philidelphia 2Health News:Igantia Announces Digital Initiative to Decode Longevity 2Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 2Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 3Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 4Health News:Shodair Children’s Hospital Retains B. E. Smith to Recruit New Administrator 2Health News:Shodair Children’s Hospital Retains B. E. Smith to Recruit New Administrator 3Health News:New AIS Newsletter Features Expert Insights and Strategies on Value-Based Care Arrangements 2
... , , LOS ANGELES, Oct. 9 ... 24th was a smashing success for the retailer known as ... tastemakers and Torrid fans packed the courtyard at the Fashion ... Runway--to celebrate fashion, honor people who work to motivate women ...
... Society of Hematology (ASH) is proud to announce ... Program, which builds hematologic capacity in developing countries. ... developing countries receive valuable clinical, laboratory, or technological ... institution under the mentorship of an ASH member ...
... Supplements help fight treatment-related bone loss, researchers say , FRIDAY, ... low levels of vitamin D, which could lead to weaker ... recommend high doses of vitamin D for them. , "Vitamin ... breast cancer have accelerated bone loss due to the nature ...
... Inc., (Pink Sheets: USFM) a diversified supplier of Farming, Nursery ... companies, Aloe Vera based Health & Beauty products can now ... websites in the world. US Farms, Inc. would like its ... Aloe365 line of Aloe Vera Juice and Skin Gel products ...
... Oct. 9 Enjoy a peaceful night,s sleep ... your partner,s incessant snoring with the Brookstone® ... and product development company recently launched its anti-snore ... helpful in reducing snoring and providing comfort without ...
... Oct. 9 The Costa Atlantica, a member of the Costa ... in a recent inspection conducted by the Centers for Disease Control ... during a stopover in New York, one of the port calls ... cruise. The cruise departed on September 16 from Savona and ended ...
Cached Medicine News:Health News:Torrid's Model Search Winners, Celebrities Celebrate Fashion and Help Support the National Breast Cancer Foundation at the House of Dreams Event 2Health News:Medical professionals from developing nations to pursue hematology training 2Health News:Vitamin D Good for Breast Cancer Patients 2Health News:US Farms, Inc. Aloe Vera Products Now Available on eBay 2Health News:US Farms, Inc. Aloe Vera Products Now Available on eBay 3Health News:Rest Assured With Clinically Tested Anti-Snore Pillow 2Health News:Costa Atlantica Receives a Perfect Score for Vessel Sanitation 2Health News:Costa Atlantica Receives a Perfect Score for Vessel Sanitation 3
... Durable ergonomic chairs with concave seats ... • Select options like seats, backrests, ... Choose the BE Series for top ... including: industry, education, laboratory, clean room, ...
... ergonomic chairs with concave seats and large ... like seats, backrests, armrests, and casters and ... top performance in a variety of environments ... control, health care and office. • With ...
... Durable ergonomic chairs with concave seats and ... options like seats, backrests, armrests, and casters ... for top performance in a variety of ... static control, health care and office. • ...
... with concave seats and large backrests ... like seats, backrests, armrests, and casters ... Series for top performance in a ... laboratory, clean room, static control, health ...
Medicine Products: